There was a good deal of financial analysis involved in the author’s conclusion, but one of his points was that Sage spent about half as much on R&D as Interact had. Of course, Interact was a much smaller company so Sage should not have needed to spend as high a percentage of revenue because it should have gained some economies of scale. Since Act is not a strategic product – it was placed in the Value Business Unit a few years ago – it wouldn’t be terribly surprising if it didn’t get top investment. SalesLogix is another story. It has a reputation of being very good, but complex. The author shows its market share diving while Microsoft CRM’s is rising steady. I would say there’s definitely truth to the gains by Dynamics CRM and I would say that at least SalesLogix hasn’t been terribly visible.